Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Biobased chemicals firms Amyris and Cobalt Technologies have raised additional funds from investors. Publicly traded Amyris will receive $28 million in cash from current stockholder Temasek and new investor Wolverine Asset Management in exchange for promissory notes. Amyris makes farnesene from sugar at its facility in Brotas, Brazil. The firm says the funding will help it achieve positive cash flow from operations in 2014. Privately held Cobalt, meanwhile, has raised $4.1 million from its backers, including Life Sciences Partners and VantagePoint Capital Partners. The company is working with two unidentified Asian chemical firms to scale up processes for converting biomass to butadiene and 1-butanol.
This article has been sent to the following recipient: